Pfizer Inc. (PFE)
29.52
+0.08
(+0.27%)
USD |
NYSE |
Oct 16, 16:00
29.57
+0.05
(+0.17%)
After-Hours: 17:43
Pfizer Price : 29.52 for Oct. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 29.57 | 29.88 | 29.42 | 29.44 | 32.89M |
| Oct 14, 2026 | 28.60 | 29.49 | 28.55 | 29.21 | 39.37M |
| Oct 13, 2026 | 28.61 | 28.61 | 28.13 | 28.37 | 26.84M |
| Oct 12, 2026 | 28.42 | 28.50 | 28.28 | 28.40 | 18.56M |
| Oct 09, 2026 | 27.61 | 28.28 | 27.59 | 28.28 | 23.20M |
| Oct 08, 2026 | 27.90 | 28.00 | 27.48 | 27.82 | 44.43M |
| Oct 07, 2026 | 27.62 | 28.17 | 27.55 | 28.00 | 31.23M |
| Oct 06, 2026 | 27.48 | 27.71 | 27.20 | 27.50 | 24.07M |
| Oct 05, 2026 | 27.65 | 27.72 | 27.12 | 27.41 | 33.01M |
| Oct 02, 2026 | 28.14 | 28.16 | 27.44 | 27.80 | 35.01M |
| Oct 01, 2026 | 28.44 | 28.58 | 28.08 | 28.12 | 30.49M |
| Sep 30, 2026 | 28.79 | 28.94 | 28.52 | 28.52 | 33.64M |
| Sep 29, 2026 | 28.60 | 28.76 | 28.26 | 28.72 | 33.31M |
| Sep 28, 2026 | 28.62 | 28.87 | 28.39 | 28.72 | 24.95M |
| Sep 25, 2026 | 28.45 | 28.69 | 28.17 | 28.67 | 27.76M |
| Sep 24, 2026 | 28.20 | 28.85 | 28.20 | 28.41 | 34.77M |
| Sep 23, 2026 | 27.96 | 28.23 | 27.84 | 28.18 | 33.81M |
| Sep 22, 2026 | 27.74 | 28.00 | 27.49 | 27.93 | 26.67M |
| Sep 21, 2026 | 27.65 | 27.92 | 27.53 | 27.74 | 28.78M |
| Sep 18, 2026 | 27.64 | 27.66 | 27.34 | 27.66 | 75.59M |
| Sep 17, 2026 | 27.62 | 27.81 | 27.55 | 27.64 | 29.01M |
| Sep 16, 2026 | 27.64 | 27.69 | 27.36 | 27.46 | 26.05M |
| Sep 15, 2026 | 27.62 | 27.66 | 27.24 | 27.55 | 40.44M |
| Sep 14, 2026 | 28.08 | 28.19 | 27.68 | 27.72 | 28.57M |
| Sep 11, 2026 | 27.80 | 27.85 | 27.42 | 27.72 | 25.56M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 255.55 |
| Eli Lilly & Co. | 1257.15 |
| Merck & Co., Inc. | 145.97 |
| Bristol Myers Squibb Co. | 59.85 |
| Viatris, Inc. | 18.66 |
Price Related Metrics
| PE Ratio | 39.09 |
| PS Ratio | 2.645 |
| Price to Book Value | 1.975 |
| Price to Free Cash Flow | 15.34 |
| Earnings Yield | 2.56% |
| Market Cap | 168.23B |
| Operating PE Ratio | 9.954 |
| Normalized PE Ratio | 12.18 |